DNYUZ
  • Home
  • News
    • U.S.
    • World
    • Politics
    • Opinion
    • Business
    • Crime
    • Education
    • Environment
    • Science
  • Entertainment
    • Culture
    • Music
    • Movie
    • Television
    • Theater
    • Gaming
    • Sports
  • Tech
    • Apps
    • Autos
    • Gear
    • Mobile
    • Startup
  • Lifestyle
    • Arts
    • Fashion
    • Food
    • Health
    • Travel
No Result
View All Result
DNYUZ
No Result
View All Result
Home Lifestyle Health

FDA approves blood test that can help diagnose Alzheimer’s disease

May 16, 2025
in Health, News
FDA approves blood test that can help diagnose Alzheimer’s disease
495
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

WASHINGTON — U.S. health officials on Friday endorsed the first blood test that can help diagnose Alzheimer’s and identify patients who may benefit from drugs that can modestly slow the memory-destroying disease.

The test can aid doctors in determining whether a patient’s memory problems are due to Alzheimer’s or a number of other medical conditions that can cause cognitive difficulties. The Food and Drug Administration cleared it for patients 55 and older who are showing early signs of the disease.

More than 6 million people in the United States and millions more around the world have Alzheimer’s, the most common form of dementia.

The new test, from Fujirebio Diagnostics, Inc., identifies a sticky brain plaque, known as beta-amyloid, that is a key marker for Alzheimer’s. Previously, the only FDA-approved methods for detecting amyloid were invasive tests of spinal fluid or expensive PET scans.

The blood test identifies a sticky brain plaque that is a key marker for Alzheimer’s. AP

The lower costs and convenience of a blood test could also help expand use of two new drugs, Leqembi and Kisunla, which have been shown to slightly slow the progression of Alzheimer’s by clearing amyloid from the brain. Doctors are required to test patients for the plaque before prescribing the drugs, which require regular IV infusions.

“Today’s clearance is an important step for Alzheimer’s disease diagnosis, making it easier and potentially more accessible for U.S. patients earlier in the disease,” said Dr. Michelle Tarver, of FDA’s center for devices.

A number of specialty hospitals and laboratories have already developed their own in-house tests for amyloid in recent years. But those tests aren’t reviewed by the FDA and generally aren’t covered by insurance. Doctors have also had little data to judge which tests are reliable and accurate, leading to an unregulated marketplace that some have called a “wild west.”

Several larger diagnostic and drug companies are also developing their own tests for FDA approval, including Roche, Eli Lilly and C2N Diagnostics.

The tests can only be ordered by a doctor and aren’t intended for people who don’t yet have any symptoms.

The post FDA approves blood test that can help diagnose Alzheimer’s disease appeared first on New York Post.

Tags: alzheimer's diseaseblood testsFDA
Share198Tweet124Share
How to Watch the Strongest Meteor Shower of the Summer
News

How to Watch the Strongest Meteor Shower of the Summer

by New York Times
August 9, 2025

Our universe might be chock-full of cosmic wonder, but you can observe only a fraction of astronomical phenomena with your ...

Read more
News

The Secret to One Swing State Democrat’s Rise? Wonky TikTok Videos.

August 9, 2025
News

Inside KPMG’s lavish Florida ‘Lakehouse,’ where interns get drumming parades, soft serve ice cream, and mini-golf

August 9, 2025
News

A Guide to Finding Insurance at 26

August 9, 2025
News

They Were Joined in Matrimony. Then They (Sometimes) Joined the Club.

August 9, 2025
Louisiana to pay $9 million to a man who was shot in the back by state trooper during traffic stop

Louisiana to pay $9 million to a man who was shot in the back by state trooper during traffic stop

August 9, 2025
Zelenskyy rejects giving up land to end war

Zelenskyy rejects giving up land to end war

August 9, 2025
13-Year-Old Complained of ‘Shoulder Pain’, Then Came Devastating Diagnosis

13-Year-Old Complained of ‘Shoulder Pain’, Then Came Devastating Diagnosis

August 9, 2025

Copyright © 2025.

No Result
View All Result
  • Home
  • News
    • U.S.
    • World
    • Politics
    • Opinion
    • Business
    • Crime
    • Education
    • Environment
    • Science
  • Entertainment
    • Culture
    • Gaming
    • Music
    • Movie
    • Sports
    • Television
    • Theater
  • Tech
    • Apps
    • Autos
    • Gear
    • Mobile
    • Startup
  • Lifestyle
    • Arts
    • Fashion
    • Food
    • Health
    • Travel

Copyright © 2025.